ZebraTox

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
NAICS	541714
Founded	2025
Employees	1-10

Key Contact at ZebraTox

Alexandria Sorensen

Co-Founder & CEO

About ZebraTox

ZebraTox is revolutionizing pre-clinical drug testing with a novel, high throughput toxicity screening platform in zebrafish. Our patent-pending genotoxicity assay bridges the gap between the cost efficacy of in vitro, toxicity studies and the translatability of live vertebrate studies to help streamline the drug development pipeline. Our goal is to reduce the risk of late-stage failures and accelerate the path to potentially life-saving therapeutics by making toxicity screening faster and more affordable than existing methods.

ZebraTox revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

ZebraTox has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

ZebraTox has never raised funding before.

Frequently asked questions

ZebraTox is located in XX.

ZebraTox was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

ZebraTox has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at ZebraTox

Alexandria Sorensen

Co-Founder & CEO

4.8

40,000 users